United States Food and Drug Administration (USFDA) has completed two successful inspections of Solara Active Pharma Science’s state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from February 17 to 21, 2020.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.
